Meningitis Encephalitis: a Metagenomics-Based Etiology & Epidemiology Research

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-12-31

Study Completion Date

2023-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Autoimmune encephalitis (AE) is caused by abnormal immune response mediated by autoimmune antibodies of patients, which can be detected by a serial of autoimmune antibodies\[4,5,6,7\]. At present, the traditional infection diagnosis mainly relies on microbial culture method, which has the characteristics of long cycle, high cost, low detection rate and complex detection process. About 30-60% of encephalitis have unknown etiology\[2,3\]. On the other hand, the diagnosis and classification of noninfectious encephalitis mainly depend on the detection of autoimmune antibodies, the scope of diagnosis and differential diagnosis is limited, and the relationship between autoimmune encephalitis and infection factors is still unclear. Metagenomics sequencing (mNGS) is a new method that does not rely on microbial culture and can directly detect pathogenic nucleic acids. It has the characteristics of fast, accurate, high throughput, no preference for different pathogen detection, and can detect known and unknown pathogens at the same time. Nowadays, mNGS is widely used in the field of pathogen detection.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Multicenter and Prospective Clinical Registry Study of Autoimmune Encephalitis in China

NCT02561260

Autoimmune Encephlitis in China

UNKNOWN

Optimal Encephalitis/Meningitis Roadmap Via Precise Diagnosis and Treatment

NCT04946682

Encephalitis Meningitis Meningoencephalitis +2 more

UNKNOWN NA

A Multicentric Cohort of Autoimmune Encephalitis

NCT06760091

Autoimmune Encephalitis

NOT_YET_RECRUITING

Risk Prediction Model for Severe Autoimmune Encephalitis

NCT06697678

Severe Autoimmune Encephalitis

NOT_YET_RECRUITING

Neuroinflammatory PET Imaging in Autoimmune Encephalomyelitis

NCT05293405

Autoimmune Encephalomyelitis

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Central Nervous System Infections and Inflammations

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Either meet the items of 1, 2 or 1, 3

1. The patient's age \>14 years old, acute or subacute onset (less than 3 months), (first onset, treatment with anti-infection drugs and/or immunotherapy ≤5 days);
2. The patient has the following symptoms:

1. Dysmnesia,
2. Seizures,
3. Mental disorders,
4. Abnormal behavior,
5. Unconsciousness or coma,
6. Dyskinesia or involuntary movement,
7. lalopathy or be reticent,
8. Dysphagia, sleep disorders, or autonomic nervous dysfunction,
9. Ataxia.
3. Patients with meningeal irritation sign, intracranial hypertension and other manifestations, satisfy at least 3 of the following symptoms:

1. Headache,
2. Fever,
3. Stiff neck,
4. Disturbance of consciousness,
5. Kernig sign or brudzinski sign was positive.

Exclusion Criteria

* 1\. Patients with suspected metabolic encephalopathy and toxic encephalopathy have the above manifestations,
* 2\. Patients with central nervous system tumor (primary or metastatic) have the above manifestations,
* 3\. The patient with non-organic mental illness,
* 4\. Patients who had undergone brain surgery within 6 months have the above symptoms after operation,
* 5\. Patients with traumatic brain injury have the above manifestations,
* 6\. Febrile convulsions caused by non-cerebral causes,
* 7\. Patients with above manifestations due to other reasons such as cerebrovascular disease, genetic disease, etc;
* 8\. Patients who refuse lumbar puncture or have contraindications to lumbar puncture;
* 9\. Patients who withdraw informed consent.

Minimum Eligible Age

14 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No